Heart failure: A case for subspecialized care management

American Heart Journal

Volumn 138, Issue 1 I, 1999, Pages 14-16

  Smith, J J ^a   Konstam, M A ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARDIOVASCULAR AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL;

CLINICAL TRIAL; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEART FAILURE; HUMAN; MEDICARE; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0032771667     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70238-3     Document Type: Editorial

References (15)

1. Konstam M, Dracup K. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. AHCPR Publication 94-0612. Rockville (MD): Department of Health and Human Services; 1994.
2. Bello D, Shah NB, Edep ME, et al. Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure. Am Heart J 1999;138:100-7.
3. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
4. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
5. Pfeffer M, et al. Effect of captopril of mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-77.
6. Chin M, et al. Differences in generalist and specialist physicians' knowledge and use of angiotensin converting enzyme inhibitors for congestive heart failure. J Gen Intern Med 1997;12:523-30.
7. Stafford R, Saglam D, Blumenthal D. National patterns of angiotensin converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997;157:2460-4.
8. The Large States Consortium. Heart failure treatment with angiotensin converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997;157:1103-8.
9. Pitt B. Results of the RALES trial. Proceedings of the American Heart Association Annual Scientific Sessions. Dallas, Texas: November 8-11, 1998.
10. Kjekshus J, et al. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail 1997;3:249-53.
11. Rich M, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
12. Rogleri J, et al. Disease management interventions to improve outcomes in congestive heart failure. Am J Man Care 1997;3:1831-9.
13. Kornowski R, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995;129:762-6.
14. Hanumanthu S, et al. Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation 1997;96 2842-8.
15. Fonarow G, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30:725-32.